Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,DPT,Dermatopontin,Inverse variance weighted,16,0.78 [0.67-0.9],0.000539183638337997,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CD302,CD302 antigen,Inverse variance weighted,6,1.26 [1.07-1.49],0.00528250823209718,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,SCG2,Secretogranin-2,Wald ratio,1,5.23 [1.63-16.7],0.00528300369077478,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,8,1.19 [1.05-1.34],0.00642206428936988,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,7,1.29 [1.07-1.56],0.00726441506453339,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,MB,Myoglobin,Wald ratio,1,0.15 [0.04-0.6],0.00751187987029078,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,8,0.8 [0.68-0.94],0.00753938687989523,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,5,0.84 [0.73-0.96],0.00877709784791245,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,NRP2,Neuropilin-2,Inverse variance weighted,10,0.75 [0.6-0.93],0.0100325243726728,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,10,1.25 [1.05-1.47],0.0100512734916191,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,7,0.82 [0.7-0.95],0.010527077442018,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,18,0.9 [0.83-0.98],0.0152476929596138,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,3,0.76 [0.61-0.95],0.0161345299427956,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,10,0.88 [0.8-0.98],0.0163105238794036,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,8,0.82 [0.69-0.97],0.0196473914102236,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,SPP1,Osteopontin,Inverse variance weighted,7,1.49 [1.06-2.08],0.0199000900052967,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,4,1.22 [1.03-1.45],0.0208660381407853,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,IL19,Interleukin-19,Inverse variance weighted,7,0.82 [0.69-0.97],0.0208860277579104,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,8,1.27 [1.04-1.56],0.0210051485033554,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CCL7,C-C motif chemokine 7,Inverse variance weighted,2,0.41 [0.19-0.88],0.0219122908806491,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CALCA,Calcitonin,Inverse variance weighted,3,2.79 [1.12-6.97],0.0275163314836758,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,TMSB10,Thymosin beta-10,Wald ratio,1,3.72 [1.14-12.11],0.0290305495341687,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,2,0.49 [0.26-0.93],0.0293438262775879,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CD59,CD59 glycoprotein,Inverse variance weighted,5,1.24 [1.02-1.52],0.0306815443332344,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,WFDC2,WAP four-disulfide core domain protein 2,Wald ratio,1,0.48 [0.24-0.94],0.0327929942351049,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,2,1.57 [1.04-2.37],0.0329253908306285,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,0.68 [0.48-0.97],0.034636726160251,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,15,0.89 [0.8-0.99],0.0360018842669399,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,7,1.18 [1.01-1.37],0.0363906463787109,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,1.2 [1.01-1.42],0.037279370438551,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,3,1.32 [1.01-1.71],0.0385760713353909,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,19,0.94 [0.88-1],0.0418198700393027,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,BTN3A2,Butyrophilin subfamily 3 member A2,Wald ratio,1,0.86 [0.74-0.99],0.0427287657001474,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,0.53 [0.28-0.98],0.0431406161197516,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,RSPO3,R-spondin-3,Inverse variance weighted,3,0.74 [0.55-0.99],0.0433828982299399,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,2,0.57 [0.33-0.98],0.0440432260321367,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,2.34 [1.01-5.46],0.0483013091406757,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,AGRN,Agrin,Inverse variance weighted,6,0.86 [0.74-1],0.0511118529349273,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,SDC1,Syndecan-1,Inverse variance weighted,3,0.72 [0.52-1],0.0513223894605259,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,4,0.72 [0.51-1.02],0.0633269492473617,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,EPO,Erythropoietin,Wald ratio,1,0.53 [0.27-1.04],0.0656464071918578,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,6,1.46 [0.98-2.17],0.066284617393721,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,4,0.81 [0.64-1.02],0.0700436223983204,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,3,1.25 [0.97-1.6],0.0826344989800157,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,OGN,Mimecan,Inverse variance weighted,24,0.92 [0.84-1.01],0.0897159997330824,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,24,1.08 [0.99-1.17],0.089835088916204,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,6,0.86 [0.72-1.03],0.0948228104260973,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,2,1.31 [0.95-1.8],0.0969792462084191,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,9,1.14 [0.98-1.33],0.100387417772808,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,FSTL1,Follistatin-related protein 1,Inverse variance weighted,3,0.76 [0.55-1.05],0.10216374715421,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,NPPC,C-type natriuretic peptide,Wald ratio,1,2.82 [0.81-9.81],0.103925166528651,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CTSV,Cathepsin L2,Inverse variance weighted,2,1.79 [0.89-3.6],0.105073234323034,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,MANSC1,MANSC domain-containing protein 1,Wald ratio,1,0.44 [0.16-1.22],0.11289830875509,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CBLN4,Cerebellin-4,Inverse variance weighted,10,0.88 [0.75-1.03],0.117695430181867,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,0.52 [0.23-1.19],0.121811504842769,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CCL3,C-C motif chemokine 3,Inverse variance weighted,6,0.89 [0.76-1.03],0.124272696153599,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,6,0.9 [0.79-1.03],0.126824688627338,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,7,0.89 [0.76-1.03],0.127371370941651,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,4,0.69 [0.42-1.12],0.129833778149134,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CSTB,Cystatin-B,Inverse variance weighted,23,0.94 [0.87-1.02],0.130840564633109,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,12,1.12 [0.97-1.29],0.132092850365053,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,7,1.15 [0.96-1.39],0.134727508868843,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,ITGA11,Integrin alpha-11,Inverse variance weighted,6,0.88 [0.74-1.04],0.136642877775611,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,DPP4,Dipeptidyl peptidase 4,Inverse variance weighted,5,0.85 [0.69-1.05],0.138173702027082,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,EDN1,Endothelin-1,Inverse variance weighted,3,1.17 [0.95-1.46],0.140134082999078,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,TGFA,Protransforming growth factor alpha,Inverse variance weighted,2,0.73 [0.48-1.11],0.142389495476098,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,GM2A,Ganglioside GM2 activator,Inverse variance weighted,16,0.94 [0.85-1.02],0.143178097129566,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CD46,Membrane cofactor protein,Wald ratio,1,1.54 [0.86-2.76],0.145694703573247,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,NTRK3,NT-3 growth factor receptor,Inverse variance weighted,5,0.86 [0.71-1.05],0.147170237634757,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,8,1.12 [0.96-1.32],0.147548361800203,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CST3,Cystatin-C,Inverse variance weighted,7,0.86 [0.7-1.06],0.152364907587871,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,5,1.12 [0.96-1.31],0.153830542358283,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,8,1.18 [0.94-1.48],0.1588511689857,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,DSC2,Desmocollin-2,Inverse variance weighted,4,0.87 [0.72-1.06],0.159542747842599,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,BSG,Basigin,Wald ratio,1,1.3 [0.9-1.89],0.160132474717263,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,DLL1,Delta-like protein 1,Inverse variance weighted,3,1.24 [0.92-1.68],0.165111368749898,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,2,1.29 [0.9-1.86],0.166630118641291,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,14,0.9 [0.77-1.05],0.166749017048172,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,20,0.95 [0.87-1.02],0.171827287537028,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,10,1.1 [0.96-1.25],0.172108675069529,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,12,0.89 [0.76-1.05],0.173561970573679,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,EFNA1,Ephrin-A1,Inverse variance weighted,8,1.11 [0.96-1.29],0.174922985406425,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,RTN4R,Reticulon-4 receptor,Inverse variance weighted,8,0.91 [0.8-1.04],0.177410420250064,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,12,0.92 [0.81-1.04],0.183159687013667,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,0.54 [0.21-1.37],0.195784092829646,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,2,1.24 [0.89-1.73],0.196200504839682,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CALB1,Calbindin,Wald ratio,1,0.52 [0.19-1.41],0.199400370161817,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,PGF,Placenta growth factor,Inverse variance weighted,2,1.78 [0.74-4.27],0.19972851092395,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,RBP2,Retinol-binding protein 2,Wald ratio,1,0.6 [0.28-1.31],0.20125671222475,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,GRN,Progranulin,Inverse variance weighted,4,0.87 [0.7-1.08],0.202724852470632,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,6,0.88 [0.73-1.07],0.209394953107973,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,LMOD1,Leiomodin-1,Inverse variance weighted,5,0.67 [0.35-1.26],0.212317513707837,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,NCS1,Neuronal calcium sensor 1,Wald ratio,1,0.76 [0.49-1.17],0.217117906754193,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,13,1.07 [0.96-1.2],0.217211105717277,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Inverse variance weighted,11,1.12 [0.94-1.33],0.218723677124006,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,TFF2,Trefoil factor 2,Inverse variance weighted,3,1.24 [0.88-1.75],0.219678719452236,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,5,0.86 [0.67-1.1],0.219810583946705,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,5,0.88 [0.72-1.08],0.220116087748972,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,IL17C,Interleukin-17C,Inverse variance weighted,3,0.75 [0.47-1.2],0.228845114972856,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,4,0.87 [0.7-1.09],0.228979689899293,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,NID1,Nidogen-1,Inverse variance weighted,4,0.8 [0.55-1.16],0.230092830607243,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,THBD,Thrombomodulin,Inverse variance weighted,5,1.19 [0.9-1.58],0.230753266916622,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CDH3,Cadherin-3,Wald ratio,1,1.51 [0.77-2.99],0.231579545978809,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CTSL,Cathepsin L1,Wald ratio,1,1.92 [0.64-5.69],0.242582951286294,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,3,1.14 [0.91-1.43],0.243901777445488,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,3,0.88 [0.72-1.09],0.245925710245114,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,16,0.92 [0.8-1.06],0.255130174323248,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,MMP12,Macrophage metalloelastase,Inverse variance weighted,15,0.95 [0.87-1.04],0.255812751229234,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,3,1.08 [0.95-1.23],0.26065873249766,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,3,0.82 [0.58-1.16],0.260972250346932,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,ORM1,Alpha-1-acid glycoprotein 1,Inverse variance weighted,14,0.94 [0.84-1.05],0.261696169914531,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Wald ratio,1,0.66 [0.32-1.37],0.265338181011171,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CD83,CD83 antigen,Inverse variance weighted,5,1.15 [0.89-1.49],0.269988311735597,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CDHR1,Cadherin-related family member 1,Inverse variance weighted,4,1.34 [0.79-2.27],0.272765094403948,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,RSPO1,R-spondin-1,Inverse variance weighted,4,1.1 [0.93-1.31],0.273436210506204,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,4,1.1 [0.93-1.29],0.274503211361634,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,3,0.91 [0.78-1.07],0.276392156567037,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.83 [0.59-1.16],0.281093441638371,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,1.84 [0.6-5.63],0.282570667545013,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,TFF1,Trefoil factor 1,Inverse variance weighted,7,0.91 [0.76-1.08],0.28365823551641,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,SHISA5,Protein shisa-5,Inverse variance weighted,3,0.78 [0.49-1.24],0.29479172375394,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,3,0.89 [0.71-1.11],0.296174496356548,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,6,1.16 [0.87-1.55],0.309116960502341,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,THBS2,Thrombospondin-2,Inverse variance weighted,12,1.07 [0.94-1.21],0.309509523141722,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,9,1.08 [0.93-1.24],0.310527448434432,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,5,1.2 [0.84-1.69],0.3130681139546,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,7,0.82 [0.56-1.21],0.317666808633795,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,ESAM,Endothelial cell-selective adhesion molecule,Wald ratio,1,1.21 [0.83-1.77],0.321020775074555,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,NOS3,"Nitric oxide synthase, endothelial",Wald ratio,1,1.74 [0.58-5.18],0.321654607122989,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,32,0.97 [0.91-1.03],0.324423815376804,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,MMP3,Stromelysin-1,Inverse variance weighted,16,1.06 [0.94-1.2],0.330495972740996,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,5,0.86 [0.63-1.17],0.331584461851012,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,ITGAV,Integrin alpha-V,Inverse variance weighted,5,1.16 [0.86-1.57],0.333612978555468,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,SNCG,Gamma-synuclein,Inverse variance weighted,13,0.95 [0.87-1.05],0.337733288368242,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,XCL1,Lymphotactin,Inverse variance weighted,15,1.04 [0.96-1.14],0.343697073322448,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,1.17 [0.85-1.6],0.345203951617805,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,FGF23,Fibroblast growth factor 23,Wald ratio,1,0.79 [0.48-1.29],0.346139143914539,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,2,0.82 [0.53-1.25],0.354859844774029,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,1.35 [0.71-2.56],0.361541861655647,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,MMP9,Matrix metalloproteinase-9,Inverse variance weighted,3,0.86 [0.61-1.2],0.364901748027737,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,2,0.76 [0.42-1.39],0.369883184988097,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,3,0.76 [0.42-1.38],0.370397756107071,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,5,0.92 [0.77-1.1],0.371111655341255,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,MZB1,Marginal zone B- and B1-cell-specific protein,Wald ratio,1,1.6 [0.57-4.55],0.373868996739765,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CD160,CD160 antigen,Inverse variance weighted,5,0.92 [0.77-1.1],0.376692630986466,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CCL18,C-C motif chemokine 18,Inverse variance weighted,5,1.18 [0.82-1.69],0.377003606706022,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,8,0.92 [0.76-1.11],0.378263060523388,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,0.82 [0.53-1.28],0.379137502341304,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,TCN2,Transcobalamin-2,Inverse variance weighted,18,0.96 [0.87-1.05],0.381155044936066,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,TFF3,Trefoil factor 3,Inverse variance weighted,3,0.83 [0.54-1.27],0.381219637646978,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,DPY30,Protein dpy-30 homolog,Wald ratio,1,1.49 [0.61-3.65],0.382632999310712,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,RNASE6,Ribonuclease K6,Inverse variance weighted,8,1.05 [0.94-1.16],0.382736221369222,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,0.89 [0.68-1.16],0.384667478484451,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,6,0.93 [0.8-1.09],0.390070615403071,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,FAM3C,Protein FAM3C,Inverse variance weighted,2,1.33 [0.69-2.56],0.391197918737832,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,3,1.33 [0.69-2.58],0.394945523074089,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,15,0.93 [0.79-1.1],0.399736846749871,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,REG1A,Lithostathine-1-alpha,Inverse variance weighted,8,1.07 [0.92-1.25],0.401977252484995,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Wald ratio,1,0.78 [0.43-1.42],0.412765460022094,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,10,0.95 [0.83-1.08],0.41347101502407,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,LGALS9,Galectin-9,Inverse variance weighted,12,1.11 [0.85-1.44],0.432673004132641,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,2,1.21 [0.75-1.93],0.435147413176679,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,9,0.92 [0.75-1.13],0.438007491907858,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,8,0.94 [0.82-1.09],0.441250955147377,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CHGA,Chromogranin-A,Inverse variance weighted,3,1.11 [0.86-1.43],0.441405591272586,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,2,1.24 [0.72-2.14],0.442320424875998,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,SEMA3F,Semaphorin-3F,Inverse variance weighted,3,1.22 [0.74-2.01],0.44620701676311,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,PRSS8,Prostasin,Inverse variance weighted,4,0.86 [0.58-1.28],0.447891185570855,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CA12,Carbonic anhydrase 12,Inverse variance weighted,9,1.05 [0.92-1.21],0.458727232759414,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,OCLN,Occludin,Wald ratio,1,0.87 [0.6-1.26],0.46034752472938,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,3,0.84 [0.52-1.34],0.462549306961775,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,3,1.2 [0.73-1.97],0.466612273904979,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,5,1.12 [0.82-1.53],0.46959003385931,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,STC1,Stanniocalcin-1,Inverse variance weighted,2,1.26 [0.67-2.38],0.47067113547327,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,AGR2,Anterior gradient protein 2 homolog,Wald ratio,1,1.19 [0.74-1.93],0.473060750562867,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,13,1.06 [0.9-1.26],0.474348767531372,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,3,1.37 [0.57-3.26],0.481583386498572,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,PTN,Pleiotrophin,Inverse variance weighted,3,1.19 [0.73-1.95],0.483809629863361,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,7,0.95 [0.82-1.1],0.501033188235907,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,13,1.05 [0.91-1.22],0.504090491673581,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,NUCB2,Nucleobindin-2,Inverse variance weighted,13,1.04 [0.92-1.19],0.509083528879651,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,AREG,Amphiregulin,Inverse variance weighted,3,1.1 [0.82-1.48],0.509236923052056,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CCL23,C-C motif chemokine 23,Inverse variance weighted,12,0.97 [0.87-1.07],0.520060868115491,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,3,1.09 [0.84-1.4],0.520643156103332,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,GDF15,Growth/differentiation factor 15,Inverse variance weighted,10,0.95 [0.8-1.12],0.523932141655439,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,0.86 [0.55-1.36],0.525211723544976,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,6,1.05 [0.91-1.21],0.52578996883896,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,DKK4,Dickkopf-related protein 4,Inverse variance weighted,3,0.92 [0.7-1.2],0.526013643796946,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,ANG,Angiogenin,Inverse variance weighted,14,1.04 [0.92-1.17],0.526592766314554,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,9,0.95 [0.81-1.12],0.527890106640759,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CD7,T-cell antigen CD7,Inverse variance weighted,3,1.06 [0.89-1.26],0.529108922751409,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,1.3 [0.57-2.96],0.529727306144984,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CD79B,B-cell antigen receptor complex-associated protein beta chain,Wald ratio,1,1.11 [0.8-1.53],0.532988442209223,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,SLAMF8,SLAM family member 8,Inverse variance weighted,14,0.98 [0.93-1.04],0.534791692002746,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,5,0.89 [0.62-1.29],0.540097548444962,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,7,0.94 [0.77-1.15],0.546598755059242,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,SIGLEC1,Sialoadhesin,Inverse variance weighted,11,0.97 [0.88-1.07],0.549362001345353,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,5,1.08 [0.84-1.4],0.550009713300407,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,6,0.92 [0.71-1.2],0.551972478299158,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,MMP7,Matrilysin,Inverse variance weighted,9,1.05 [0.89-1.23],0.554217404561911,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,INHBB,Inhibin beta B chain,Inverse variance weighted,6,0.96 [0.84-1.1],0.555196144704544,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,1.07 [0.86-1.33],0.560322567107833,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,FABP5,Fatty acid-binding protein 5,Wald ratio,1,1.15 [0.71-1.88],0.56442028247214,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,PRSS2,Trypsin-2,Inverse variance weighted,3,1.1 [0.8-1.51],0.568415213107133,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,6,0.95 [0.8-1.13],0.568956034542087,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,8,1.03 [0.92-1.16],0.569562704185084,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,4,1.13 [0.74-1.71],0.571252000400308,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,5,1.08 [0.83-1.41],0.573338065360909,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,FCN1,Ficolin-1,Inverse variance weighted,9,0.95 [0.8-1.14],0.58949173977875,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,ULBP2,UL16-binding protein 2,Inverse variance weighted,13,1.03 [0.92-1.16],0.589973836510465,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,KLK11,Kallikrein-11,Inverse variance weighted,2,1.03 [0.92-1.16],0.590870459821624,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,MMP8,Neutrophil collagenase,Inverse variance weighted,11,1.03 [0.92-1.16],0.592414887894589,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,12,0.96 [0.83-1.11],0.593699353962025,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,UMOD,Uromodulin,Inverse variance weighted,18,1.02 [0.94-1.12],0.595464247339499,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,FOLR1,Folate receptor alpha,Inverse variance weighted,3,0.9 [0.61-1.33],0.598440743675458,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,PRG2,Bone marrow proteoglycan,Wald ratio,1,1.15 [0.68-1.96],0.603181097425472,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,14,1.03 [0.91-1.17],0.603232816233286,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,3,0.94 [0.75-1.19],0.613864235452161,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,21,1.02 [0.94-1.11],0.616957531858682,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,10,1.04 [0.89-1.21],0.61790600677125,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,FCRLB,Fc receptor-like B,Inverse variance weighted,16,1.02 [0.94-1.11],0.618503919691041,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,8,0.97 [0.86-1.09],0.620395136015493,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,ANGPT2,Angiopoietin-2,Inverse variance weighted,4,1.08 [0.79-1.49],0.623569295544161,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,5,0.92 [0.65-1.29],0.623643924504705,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,4,0.85 [0.44-1.64],0.624607948245167,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,6,1.04 [0.9-1.19],0.625467059159563,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,4,1.07 [0.82-1.39],0.630057615297381,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,22,1.02 [0.95-1.09],0.633487935324204,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CCN5,CCN family member 5,Inverse variance weighted,3,0.9 [0.58-1.4],0.63561112042985,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,3,1.04 [0.89-1.2],0.636009962615924,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CHGB,Secretogranin-1,Inverse variance weighted,17,1.04 [0.88-1.23],0.643055409166449,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,JAM2,Junctional adhesion molecule B,Wald ratio,1,0.76 [0.24-2.41],0.643055714683878,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,PSAP,Prosaposin,Inverse variance weighted,4,1.05 [0.84-1.32],0.646421902120924,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,NECTIN4,Nectin-4,Inverse variance weighted,6,1.06 [0.83-1.36],0.648367696851616,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,WNT9A,Protein Wnt-9a,Inverse variance weighted,2,0.66 [0.11-3.97],0.649018695531358,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.88 [0.49-1.58],0.658135493660583,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,12,0.97 [0.86-1.1],0.658326793983296,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,TFRC,Transferrin receptor protein 1,Inverse variance weighted,18,0.97 [0.84-1.11],0.658709597903117,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CLMP,CXADR-like membrane protein,Inverse variance weighted,9,1.03 [0.9-1.19],0.658866282236781,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,HGF,Hepatocyte growth factor,Inverse variance weighted,2,0.89 [0.54-1.48],0.662325679961262,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,8,0.96 [0.82-1.14],0.665499893585748,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,TXNDC5,Thioredoxin domain-containing protein 5,Inverse variance weighted,2,1.13 [0.64-2.01],0.668073709232327,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,SPON1,Spondin-1,Inverse variance weighted,10,1.04 [0.87-1.25],0.669168604977163,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,2,0.86 [0.42-1.75],0.669551232962039,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,10,1.05 [0.84-1.3],0.67128478238273,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,1.11 [0.68-1.82],0.679957351882617,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,8,0.96 [0.79-1.16],0.67999504058799,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,PENK,Proenkephalin-A,Inverse variance weighted,11,1.03 [0.9-1.18],0.680888318072224,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,LGALS4,Galectin-4,Inverse variance weighted,3,0.92 [0.62-1.37],0.684953864706512,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,3,1.05 [0.82-1.36],0.686401806237545,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,PPL,Periplakin,Wald ratio,1,0.88 [0.48-1.63],0.695657358591953,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,1.04 [0.86-1.25],0.696500495677461,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,14,1.03 [0.87-1.23],0.703041948818091,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,COLEC12,Collectin-12,Inverse variance weighted,7,0.92 [0.61-1.39],0.703062079025722,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,HSPB6,Heat shock protein beta-6,Wald ratio,1,1.3 [0.34-5.02],0.704579744541206,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,MDK,Midkine,Inverse variance weighted,3,0.88 [0.46-1.7],0.709776190394396,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,IGLC2,Immunoglobulin lambda constant 2,Wald ratio,1,0.89 [0.48-1.65],0.711970700463257,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,1.03 [0.86-1.24],0.715691338902515,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,8,0.97 [0.83-1.13],0.716733287420762,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,3,1.11 [0.64-1.91],0.718867740544063,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CD300C,CMRF35-like molecule 6,Wald ratio,1,1.07 [0.75-1.51],0.72024365469183,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,14,1.03 [0.89-1.18],0.720914139274843,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,5,1.09 [0.68-1.76],0.722497154772625,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,5,0.94 [0.67-1.32],0.722765107022121,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,2,0.93 [0.64-1.36],0.725139322380937,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CCL16,C-C motif chemokine 16,Inverse variance weighted,10,0.99 [0.92-1.06],0.731495612994302,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CCN3,CCN family member 3,Inverse variance weighted,13,1.03 [0.88-1.2],0.735570411116317,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,VWC2,Brorin,Inverse variance weighted,15,0.98 [0.87-1.1],0.738173912803176,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,GRPEL1,"GrpE protein homolog 1, mitochondrial",Wald ratio,1,1.22 [0.38-3.92],0.738929148524058,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Wald ratio,1,1.08 [0.7-1.65],0.739849515090756,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,NRP1,Neuropilin-1,Inverse variance weighted,8,1.03 [0.85-1.26],0.746139663876177,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,LBP,Lipopolysaccharide-binding protein,Inverse variance weighted,12,1.02 [0.9-1.15],0.750196500612656,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,FBLN2,Fibulin-2,Inverse variance weighted,3,0.95 [0.68-1.32],0.753770065144238,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,0.97 [0.79-1.18],0.75685128381441,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,6,1.02 [0.88-1.2],0.756942286498523,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,ELN,Elastin,Wald ratio,1,1.1 [0.6-2.04],0.757395179563178,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,LGALS3,Galectin-3,Inverse variance weighted,14,0.98 [0.84-1.13],0.758074066420558,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,12,1.03 [0.87-1.22],0.758814615676559,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,RGMB,RGM domain family member B,Inverse variance weighted,6,0.95 [0.7-1.29],0.761615269365601,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,EFNA4,Ephrin-A4,Wald ratio,1,0.86 [0.31-2.4],0.769772626474722,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,KLK4,Kallikrein-4,Inverse variance weighted,8,0.98 [0.87-1.11],0.772652509389372,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,7,1.02 [0.87-1.21],0.77433346609724,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CCL20,C-C motif chemokine 20,Wald ratio,1,0.92 [0.53-1.61],0.775569298681184,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,RNASET2,Ribonuclease T2,Inverse variance weighted,9,0.98 [0.86-1.12],0.781581043770307,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,2,1.06 [0.71-1.58],0.781712733878552,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,LGALS1,Galectin-1,Inverse variance weighted,4,1.04 [0.8-1.34],0.783131639318412,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,3,0.9 [0.42-1.93],0.793491952597306,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CFD,Complement factor D,Inverse variance weighted,7,1.05 [0.72-1.54],0.797732074779503,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,PALM2,Paralemmin-2,Inverse variance weighted,8,1.03 [0.84-1.25],0.798309814759349,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,DTNB,Dystrobrevin beta,Wald ratio,1,1.17 [0.35-3.88],0.802774929465922,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,SERPINA3,Alpha-1-antichymotrypsin,Inverse variance weighted,5,1.04 [0.75-1.44],0.808705198259657,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,SPON2,Spondin-2,Inverse variance weighted,4,1.03 [0.82-1.28],0.810661719122433,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,0.94 [0.55-1.6],0.813574635127366,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,13,0.98 [0.8-1.2],0.826595357861199,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,HSPA2,Heat shock-related 70 kDa protein 2,Inverse variance weighted,2,0.95 [0.6-1.51],0.826970963898535,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,ADM,Pro-adrenomedullin,Wald ratio,1,0.95 [0.57-1.58],0.8348306763136,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CCL15,C-C motif chemokine 15,Inverse variance weighted,11,0.99 [0.91-1.08],0.835903633465018,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,13,1.01 [0.93-1.09],0.837394405602358,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,1.05 [0.64-1.73],0.837878820103253,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,SERPINF1,Pigment epithelium-derived factor,Inverse variance weighted,8,1.02 [0.86-1.2],0.83818805116468,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,6,0.99 [0.89-1.1],0.843359371882641,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CD27,CD27 antigen,Inverse variance weighted,8,1.02 [0.86-1.19],0.843644354957958,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,C5,Complement C5,Inverse variance weighted,2,1.05 [0.65-1.67],0.851805581725305,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,15,0.99 [0.87-1.12],0.8518623885058,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,4,0.97 [0.74-1.28],0.852371864373992,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,2,1.03 [0.72-1.49],0.854362999744531,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,REG1B,Lithostathine-1-beta,Inverse variance weighted,10,1.01 [0.89-1.15],0.859847194093068,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CD300A,CMRF35-like molecule 8,Inverse variance weighted,3,0.98 [0.74-1.29],0.86320809675005,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,11,1.01 [0.88-1.16],0.864698582827897,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,9,0.98 [0.82-1.18],0.865277922365428,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,20,1.01 [0.93-1.1],0.868115385880262,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CCL14,C-C motif chemokine 14,Inverse variance weighted,9,0.98 [0.79-1.22],0.873605497241664,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,FAP,Prolyl endopeptidase FAP,Inverse variance weighted,3,1.02 [0.82-1.26],0.875096073338954,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,4,0.98 [0.81-1.19],0.876058122158146,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CD48,CD48 antigen,Inverse variance weighted,7,1.02 [0.83-1.25],0.876350542282215,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,0.93 [0.36-2.43],0.881521995950724,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,4,0.97 [0.62-1.5],0.883546064356735,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,2,1.02 [0.75-1.39],0.888515842750648,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,GUCA2A,Guanylin,Inverse variance weighted,4,0.98 [0.71-1.35],0.889698889016863,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,13,0.99 [0.89-1.11],0.89005869321659,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,0.92 [0.25-3.29],0.893144065020504,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,10,0.99 [0.91-1.09],0.893954136530283,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,7,0.98 [0.75-1.28],0.895530868628481,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,EGFR,Epidermal growth factor receptor,Inverse variance weighted,8,1.01 [0.81-1.28],0.903099873526729,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,IL10,Interleukin-10,Wald ratio,1,0.97 [0.59-1.6],0.905419413117346,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,RNASE4,Ribonuclease 4,Inverse variance weighted,8,1.01 [0.84-1.22],0.907658040124292,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CCL22,C-C motif chemokine 22,Inverse variance weighted,4,1.02 [0.76-1.35],0.916586935706029,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,6,1.02 [0.69-1.51],0.921578692355625,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CALB2,Calretinin,Wald ratio,1,0.96 [0.42-2.21],0.92868281886639,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,NECTIN2,Nectin-2,Inverse variance weighted,3,0.99 [0.72-1.34],0.930428769483809,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CTSZ,Cathepsin Z,Wald ratio,1,1.06 [0.29-3.93],0.932136881774355,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,14,0.99 [0.83-1.18],0.932847503701487,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CD300E,CMRF35-like molecule 2,Inverse variance weighted,7,1.01 [0.88-1.15],0.939558545712056,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,4,1.01 [0.78-1.32],0.941788979852385,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,FAM3B,Protein FAM3B,Inverse variance weighted,8,1 [0.91-1.1],0.943168661393512,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,RETN,Resistin,Inverse variance weighted,4,1.01 [0.85-1.18],0.950812083190379,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,1.02 [0.55-1.87],0.951092990464797,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,PGA4,Pepsin A-4,Inverse variance weighted,2,1.02 [0.45-2.34],0.954032157418848,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,REN,Renin,Inverse variance weighted,3,1.02 [0.45-2.34],0.960858057809097,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,5,1 [0.88-1.15],0.962944826835111,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,LAYN,Layilin,Inverse variance weighted,12,1 [0.84-1.18],0.968189573463573,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,18,1 [0.91-1.09],0.969833016981002,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,Inverse variance weighted,19,1 [0.89-1.12],0.971475518344209,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,AMBP,Protein AMBP,Inverse variance weighted,3,0.99 [0.68-1.46],0.975651381787351,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,PDCD1,Programmed cell death protein 1,Inverse variance weighted,2,1.01 [0.61-1.67],0.976513299163558,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,6,1 [0.77-1.3],0.977345049779099,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,12,1 [0.85-1.17],0.979558802994882,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,7,1 [0.85-1.17],0.98103866674622,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,PCDH12,Protocadherin-12,Inverse variance weighted,5,1 [0.82-1.21],0.982428153500298,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,PI3,Elafin,Inverse variance weighted,7,1 [0.88-1.14],0.990587803761721,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,20,1 [0.93-1.08],0.992521558639344,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,ADA2,Adenosine deaminase 2,Inverse variance weighted,3,1 [0.8-1.24],0.998290043016359,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,5,1 [0.74-1.35],0.999292760721132,cis
